Frontlight ResearchEarly access
Head and neck cancer trials in France
91 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Lyon, Paris, Saint-Herblain, Villejuif
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - Phase 4Not yet taking people in FrancePharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.
- Where
- Nice Cedex 2
- Age
- 18 years and over
- People
- 110
- Run by
- Centre Antoine Lacassagne
See details and how to joinNCT07633613 · EU 2026-526866-26-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Besançon, Levallois-Perret, Marseille, Neuilly, Paris
- Age
- 18 years and over
- People
- 2,285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - No phaseTaking peoplePrediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
- Where
- Aurillac, Clermont-Ferrand, Lyon, Saint-Etienne
- Age
- 18 years to 80 years
- People
- 63
- Run by
- Centre Jean Perrin
See details and how to joinNCT05710679 - Phase 1/2Taking peopleFirst in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Where
- Paris, Villejuif
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06657222 · EU 2025-522517-35-00 - Phase 2Taking peopleReduction in the number of chemotherapy cycles in combination with Pembrolizumab in first-line treatment of PD-L1-positive recurrent or metastatic head and neck squamous cell carcinomas
- Where
- Amiens Cedex 1, Avignon Cedex 9, Bordeaux, Clermont-Ferrand, Limoges, Marseille, Nantes, Nice Cedex 2, Nimes Cedex 9, Poitiers, Rennes Cedex, Toulouse, Toulouse Cedex 3
- Age
- 18 years and over
- People
- 86
- Run by
- Oncopole Claudius Regaud
See details and how to join2024-514875-16-00 - Phase 1/2Taking peopleSafety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma
- Where
- Angers, Bordeaux, Lyon, Marseille, Montpellier Cedex 5, Paris, Saint-Cloud, Saint-Herblain Cedex, Villejuif
- Age
- 18 years and over
- People
- 110 worldwide
- Run by
- Nykode Therapeutics ASA
See details and how to joinNCT06016920 · EU 2022-503055-26-00 - No phaseTaking peopleEvaluation of the Efficacy and Safety of Local Cryotherapy Treatment of Recurrent Head and Neck Cancer in Irradiated Areas: a Pilot Study
- Where
- Strasbourg
- Age
- 18 years and over
- People
- 15
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT05738187 - No phaseTaking peopleAssociation Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study
- Where
- Paris
- Age
- 18 years and over
- People
- 140
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05946577 - Phase 1/2Taking peopleA Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Where
- Villejuif
- Age
- 18 years and over
- People
- 366 worldwide
- Run by
- Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01 - Phase 1/2Taking peopleA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Clermont Ferrand Cedex1, Dijon, La Tronche, Lyon, Marseille, Nantes, Pessac, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00 - Phase 3Taking peopleStudy on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
- Where
- Avignon, Besançon, Bordeaux, Caen, Carcassonne, Clermont-Ferrand, Dijon, Le Havre, Le Mans, Lille, Lorient, Lyon, Marseille, Montbéliard, Nice, Reims, Rouen, Saint-Priest-en-Jarez, Strasbourg, Tarbes, Toulouse, Valence, Vandœuvre-lès-Nancy, Villejuif
- Age
- 18 years and over
- People
- 102
- Run by
- UNICANCER
See details and how to joinNCT04747054 - No phaseTaking peopleFeasibility Study on the Implementation of a Supervised, Home-based Adapted Physical Activity Program for Patients With Head and Neck Cancer
- Where
- Rouen
- Age
- 18 years and over
- People
- 66
- Run by
- Centre Henri Becquerel
See details and how to joinNCT07560397 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Bordeaux, Paris, Villejuif
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - No phaseNot yet taking people in FranceSPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer
- Where
- Brest, Caen, Dijon, LE HAVRE, Lille, Montpellier, Paris, Rouen, Strasbourg, Tours
- Age
- 18 years and over
- People
- 128
- Run by
- UNICANCER
See details and how to joinNCT07241273 - No phaseTaking peopleDiagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.
- Where
- Brest
- Age
- 18 years and over
- People
- 180
- Run by
- University Hospital, Brest
See details and how to joinNCT07417605 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Bordeaux, Lyon, Marseille, Nice Cedex 2, Toulouse, Villejuif
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - No phaseTaking peopleEvolution of Masticatory Function, Orofacial Functions and Quality of Life of Patients Treated for Cancers of the Upper Aerodigestive Tract, Rehabilitated by Maxillofacial Prostheses.
- Where
- Clermont-Ferrand
- Age
- 18 years and over
- People
- 50
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT07471451 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Angers, Nice Cedex 2, Poitiers, Vandouvre Les Nancy, Villejuif
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - No phaseTaking peopleInnovative OSA Screening in Head and Neck Cancer Patients With the Apneal App
- Where
- Caen
- Age
- 18 years and over
- People
- 20
- Run by
- University Hospital, Caen
See details and how to joinNCT06896448 - No phaseTaking peopleEvaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Age
- 18 years and over
- People
- 70
- Run by
- University Hospital, Angers
See details and how to joinNCT06971848 - No phaseTaking peopleIdentification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
- Where
- Strasbourg
- Age
- 18 years and over
- People
- 60
- Run by
- Centre Paul Strauss
See details and how to joinNCT05328024 - Phase 1Taking peopleStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Where
- Marseille, Nice, Suresnes, Toulouse
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00 - Phase 3Taking peopleA Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- Where
- Caen Cedex 5, Dijon, Marseille, Metz Cedex 03, Poitiers, Quimper Cedex, Rennes Cedex, Rouen Cedex, Vandouvre Les Nancy
- Age
- 18 years and over
- People
- 864 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06256588 · EU 2023-508613-17-00 - Phase 3Taking peopleStudy Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN
- Where
- Amiens Cedex 1, Angers, Avignon, Bobigny Cedex, Bordeaux Cedex, Brest, Caen Cedex 5, Clermont-Ferrand, Créteil, Epagny Metz-tessy, La Chaussee St Victor, La Roche Sur Yon Cedex 9, Le Havre, Le Mans, Lille, Lorient, Lyon, Marseille, Montpellier Cedex 5, Nantes, Nice Cedex 2, Nimes Cedex 9, Osny, Paris, Paris Cedex 20, Reims Cedex, Saint-Herblain Cedex, SAINT-MALO, Saint Nazaire Cedex, Sarcelles, Strasbourg, Toulon, Tours Cedex 9, Trévenans, Valence, Vandoeuvre Les Nancy_ Cedex, Villejuif
- Age
- 18 years to 80 years
- People
- 780 worldwide
- Run by
- Groupe Oncologie Radiotherapie Tete et Cou
See details and how to joinNCT07264075 · EU 2025-522996-27-00